Skip to main
PRA
PRA logo

ProAssurance (PRA) Stock Forecast & Price Target

ProAssurance (PRA) Analyst Ratings

Based on 3 analyst ratings
Hold
Strong Buy 0%
Buy 33%
Hold 67%
Sell 0%
Strong Sell 0%

Bulls say

ProAssurance Corp's net investment income demonstrated a notable increase of 9.0% to $37.0 million, exceeding both internal estimates and consensus expectations, which reflects the company's effective investment strategy and robust financial management. Additionally, the stability of premiums in the medical malpractice segment indicates a resilient core business, providing a level of confidence amid challenges in other lines of insurance. Together, these factors contribute to a favorable outlook on the company's overall financial health and operational performance.

Bears say

ProAssurance Corp has reported a 2.3% decline in net premiums written, totaling $276.1 million, which fell short of both internal estimates and market consensus. This decrease not only reflects a downward trend compared to the prior year but also indicates challenges in maintaining revenue generation, particularly in its key Specialty Property and Casualty segment. Additionally, the company’s underwriting results were notably worse than expected, contributing to a negative outlook on its financial performance.

ProAssurance (PRA) has been analyzed by 3 analysts, with a consensus rating of Hold. 0% of analysts recommend a Strong Buy, 33% recommend Buy, 67% suggest Holding, 0% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of ProAssurance and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About ProAssurance (PRA) Forecast

Analysts have given ProAssurance (PRA) a Hold based on their latest research and market trends.

According to 3 analysts, ProAssurance (PRA) has a Hold consensus rating as of Oct 30, 2025. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $21, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $21, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

ProAssurance (PRA)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.